PTC Therapeutics | PTCT - Trade Debtors


PTC Therapeutics reported $203.07M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 139.44M 19.75M Sep/2025
Alnylam Pharmaceuticals USD 964.77M 397.66M Sep/2025
Amgen USD 8.49B 211M Sep/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Gilead Sciences USD 5.1B 314M Sep/2025
Incyte USD 895.89M 53M Sep/2025
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
Novartis USD 8.98B 192M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
PTC Therapeutics USD 203.07M 6.94M Sep/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
TG Therapeutics USD 265.38M 33.86M Sep/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 1.95B 52.9M Sep/2025
Xencor USD 21.8M 25.75M Sep/2025